These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 18804404

  • 1. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [Abstract] [Full Text] [Related]

  • 2. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K.
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [Abstract] [Full Text] [Related]

  • 3. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis.
    Zhu L, Wang N.
    Surg Oncol; 2013 Sep; 22(3):190-4. PubMed ID: 23849685
    [Abstract] [Full Text] [Related]

  • 4. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
    Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, Saito M, Otsuki N, Nibu K, Sugimura K.
    Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
    [Abstract] [Full Text] [Related]

  • 5. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G, Brouwer J, de Bree R, Pruim J, van der Laan BF, Vaalburg W, Hoekstra OS, Comans EF, Vissink A, Leemans CR, Roodenburg JL.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [Abstract] [Full Text] [Related]

  • 6. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S.
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [Abstract] [Full Text] [Related]

  • 7. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Ianora AA, Asabella AN.
    Rev Esp Med Nucl Imagen Mol; 2014 Oct; 33(1):22-7. PubMed ID: 23948509
    [Abstract] [Full Text] [Related]

  • 8. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 9. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI, Kim SK, Paeng JC, Lee HY.
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [Abstract] [Full Text] [Related]

  • 10. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
    Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A.
    Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
    [Abstract] [Full Text] [Related]

  • 12. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 13. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP, Kwee TC, Fijnheer R, Beek FJ, de Klerk JM, Nievelstein RA.
    J Comput Assist Tomogr; 2014 Sep 20; 38(4):620-5. PubMed ID: 24681861
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Büll U.
    Nuklearmedizin; 1999 Sep 20; 38(8):312-8. PubMed ID: 10615664
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
    Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF, ChangLai SP, Chieng PU.
    Ann Otol Rhinol Laryngol; 2000 Dec 20; 109(12 Pt 1):1130-4. PubMed ID: 11130825
    [Abstract] [Full Text] [Related]

  • 16. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM, Keyes JW, Williams DW, McGuirt WF, Joyce WT.
    Cancer; 1999 Jul 01; 86(1):114-8. PubMed ID: 10391570
    [Abstract] [Full Text] [Related]

  • 17. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, Stennert E.
    Otolaryngol Head Neck Surg; 2000 Sep 01; 123(3):294-301. PubMed ID: 10964310
    [Abstract] [Full Text] [Related]

  • 18. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
    Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V.
    Eur Radiol; 2014 Apr 01; 24(4):889-901. PubMed ID: 24322510
    [Abstract] [Full Text] [Related]

  • 19. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
    Alfonso A, Redondo M, Rubio T, Del Olmo B, Rodríguez-Wilhelmi P, García-Velloso MJ, Richter JA, Páramo JA, Lecumberri R.
    Int J Cancer; 2013 Nov 01; 133(9):2157-64. PubMed ID: 23616232
    [Abstract] [Full Text] [Related]

  • 20. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L.
    Acad Radiol; 2014 May 01; 21(5):675-84. PubMed ID: 24703482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.